524731 — Jenburkt Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹3.26bn
- IN₹2.70bn
- IN₹1.37bn
- 97
- 44
- 58
- 80
Annual cashflow statement for Jenburkt Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 266 | 211 | 165 | 223 | 246 |
| Depreciation | |||||
| Non-Cash Items | -30 | -35.2 | 15.2 | 34.3 | 44.6 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -120 | -49 | -6 | -182 | -143 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 130 | 150 | 195 | 94 | 171 |
| Capital Expenditures | -24 | -45.5 | -11.5 | -30.5 | -21 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -81.3 | 16.8 | -176 | 17.2 | 47.2 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -105 | -28.8 | -188 | -13.3 | 26.2 |
| Financing Cash Flow Items | -9.52 | -22.5 | -2.04 | -3.41 | -5.17 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -24.2 | -108 | -7.14 | -55.3 | -210 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.431 | 13.1 | -0.403 | 25.4 | -13.7 |